Source: International Congress 2017 – Markers of COPD progression
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Karadeniz (IZMIR, Turkey). The comparison of eosinophilic and non-eosinophilic  stable COPD patients. 1088

Member's Comments

No comment yet.

Related content which might interest you: Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD? Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 The importance of eosinophilic inflammation in COPD exacerbations Source: International Congress 2017 – COPD management Year: 2017 Mepolizumab efficacy in patients with severe eosinophilic asthma and bronchiectasis Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Pulmonary hypertension in eosinophilic versus noneosinophilic COPD Source: ERJ Open Res, 7 (1) 00772-2020; 10.1183/23120541.00772-2020 Year: 2021 The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 The rate of re-exacerbation in patients hospitalized with eosinophil and non-eosinophilic COPD relapses Source: Virtual Congress 2020 – Phenotypes of obstructive diseases Year: 2020 Airway inflammation in non-eosinophilic atopic asthma: comparisons with eosinophilic atopic asthma and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 733s Year: 2005 Rapid Benralizumab effectiveness in patients with severe eosinophilic asthma and bronchiectasis Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 COPD and asthma overlap with bronchiectasis Source: Eur Respir Monogr 2018; 81: 167-185 Year: 2018 Inflammatory cell counts in induced sputum from non-allergic asthmatics and COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004 Sputum analysis reveals eosinophilic inflammation in difficult-to-control asthma patients with low blood eosinophils and FENO. Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Catabolic/anabolic balance in patients with COPD exacerbation Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004 Is the unclassifiable obstructive airway more similar to asthma than COPD? Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 A study on the pulmonary function of patients with chronic eosinophilic pneumonia Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Asthma exacerbations and eosinophilic inflammation 6 months after treatment with mepolizumab in refractory eosinophilic asthma Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Care-continuity for COPD patients Source: Annual Congress 2012 - Nursing led education and follow-up strategies: impact on readmission, self care and patient experiences Year: 2012 COPD patients Source: Eur Respir Monogr 2021; 90: 154-164 Year: 2021 Comparison of residual eosinophilic inflammation in the distal airway of patients with well-controlled asthma using different drug combinations of asthma treatment Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 Neutrophilic inflammation in severe asthmatics and COPD patients with the same severity of airway obstruction Source: Eur Respir J 2002; 20: Suppl. 38, 505s Year: 2002 Clinical response to mepolizumab in patients with severe eosinophilic asthma Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019